BioSpace News Archive

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be featured as a presenting company at the 22nd Annual Global Investment Conference sponsored by H.C Wainwright.

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI) , a medical device company focused on the design and development of single-port robotic surgical technologies, today announced that it is scheduled to present at the H.C. Wainwright Investor Conference on Monday, September 14, 2020 at 2:00 PM ET. David McNally, President and CEO of Titan will be presenting to a live virtual audience available by webcast at

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that RedHill’s Chief Executive Officer, Dror Ben-Asher, will present at the Morgan Stanley Annual Global Healthcare Conference, on Thursday, September 17, 2020.

Amarin Corporation plc announced that John F. Thero, Amarin’s president and chief executive officer, is scheduled to present at the 2020 Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 from 11:20 - 11:50 a.m. Eastern Time.

Results show clinical study design may influence performance estimates and published sensitivity claims of SARS-CoV-2 antigen tests

Version 4.95 of Telemis-Medical offers greater scope for configuration, as well as addressing increasingly important GDPR and data security factors

Orthofix Medical Inc. announced support for the U.S. Food and Drug Administration Medical Devices Advisory Committee, Orthopaedic and Rehabilitative Devices Panel recommendation to require robust and complete clinical data for the proposed reclassification of bone growth stimulators from Class III to Class II with “special controls” to ensure patient safety and therapy efficacy.

Revolution Medicines, Inc., a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers, announced that Mark A. Goldsmith, M.D., Ph.D., chief executive officer and chairman, will deliver a corporate presentation as part of the H.C. Wainwright 22nd Annual Global Investment Conference.

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HOOKIPA’s management team will participate in the following virtual investor conferences in September: H.C. Wainwright 22 nd Annual Global Investment Conference, September 14-16, 2020 Presentation: Monday, September

Kraton Corporation (NYSE: KRA), a leading global producer of specialty polymers and high-value biobased products derived from pine wood pulping co-products, is seeking regulatory ap